Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.

[1]  H. Wada,et al.  Meta-analysis of postoperative adjuvant chemotherapy with tegafur-uracil in non-small-cell lung cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  M. Okada,et al.  Prognostic significance of perioperative serum carcinoembryonic antigen in non-small cell lung cancer: analysis of 1,000 consecutive resections for clinical stage I disease. , 2004, The Annals of thoracic surgery.

[3]  M Paesmans,et al.  CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients , 2004, British Journal of Cancer.

[4]  H. Dienemann,et al.  CYFRA 21-1 and CEA are independent prognostic factors in 153 operated stage I NSCLC patients. , 2004, Anticancer research.

[5]  Y. Matsuzaki,et al.  Prognostic significance of preoperative serum carcinoembryonic antigen level in lung adenocarcinoma but not squamous cell carcinoma. , 2004, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

[6]  J. Kulpa,et al.  Carcinoembryonic antigen, squamous cell carcinoma antigen, CYFRA 21-1, and neuron-specific enolase in squamous cell lung cancer patients. , 2002, Clinical chemistry.

[7]  M. Brundage,et al.  Prognostic factors in non-small cell lung cancer: a decade of progress. , 2002, Chest.

[8]  M. Ohta,et al.  Serum carcinoembryonic antigen level in surgically resected clinical stage I patients with non-small cell lung cancer. , 2002, The Annals of thoracic surgery.

[9]  Michael Thomas,et al.  Prognostic impact of Cyfra21-1 and other serum markers in completely resected non-small cell lung cancer. , 2002, Lung cancer.

[10]  J L Pujol,et al.  Cyfra 21-1, neuron specific enolase and prognosis of non-small cell lung cancer: prospective study in 621 patients. , 2001, Lung cancer.

[11]  K. Eguchi,et al.  Evaluation of the relationship between serum carcinoembryonic antigen level and treatment outcome in surgically resected clinical-stage I patients with non-small-cell lung cancer. , 2000, Anticancer research.

[12]  R. Miceli,et al.  Tumour markers CEA, NSE, SCC, TPA and CYFRA 21.1 in resectable non-small cell lung cancer. , 1999, Anticancer research.

[13]  T. Peretz,et al.  Prognostic value of CYFRA 21-1, TPS and CEA in different histologic types of non-small cell lung cancer. , 1999, Anticancer research.

[14]  D. Niewoehner,et al.  Serum carcinoembryonic antigen as an adjunct to preoperative staging of lung cancer. , 1998, The Journal of thoracic and cardiovascular surgery.

[15]  T. Peretz,et al.  Evaluation of tissue polypeptide specific antigen, CYFRA 21‐1, and carcinoembryonic antigen in nonsmall cell lung carcinoma , 1998, Cancer.

[16]  S. Chevret,et al.  Diagnostic and prognostic value of Cyfra 21-1 compared with other tumour markers in patients with non-small cell lung cancer: a prospective study of 116 patients. , 1997, European journal of cancer.

[17]  J. Nikliński,et al.  Preoperative CYFRA 21-1 level as a prognostic indicator in resected primary squamous cell lung cancer. , 1996, British Journal of Cancer.

[18]  J. Régnard,et al.  Preoperative carcinoembryonic antigen level as a prognostic indicator in resected primary lung cancer. , 1994, The Annals of thoracic surgery.

[19]  M. Gion,et al.  Evaluation of Cytokeratin 19 Serum Fragments (Cyfra 21–1) in Patients with Lung Cancer: Results of a Multicenter Trial , 1994, The International journal of biological markers.

[20]  H Dienemann,et al.  CYFRA 21‐1: A new marker in lung cancer , 1993, Cancer.

[21]  G. Liebler,et al.  Prognostic value of preoperative carcinoembryonic antigen (CEA) plasma levels in patients with bronchogenic carcinoma , 1978, Cancer.